Nusano News
Nusano Named Researcher of the Year at Inaugural Best of BioHive Awards
[dsm_image_carousel gallery_ids="292288,292284,292285,292287,292286,292280" sizes="thumbnail" lazyload="on" centered_slides="on" autoplay_speed="4000"...
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
Nusano and PharmaLogic will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.
Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
Nusano is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains.
Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day
Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will participate in a fireside chat at the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day in New York City on Monday, May 15, 2023.
Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals
Nusano is hosting a virtual Key Opinion Leader (KOL) event on Friday, May 12, 2023 at 10 a.m. EST. The event will highlight the rapidly expanding and critically undersupplied medical radioisotopes market, including current limitations and what must be overcome to improve patient care and unlock market potential.
Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group
Nusano will present an overview of the company’s breakthrough production platform to the European Cooperation in Science and Technology (COST) Astatine-211 Working Group on May 4, 2023. Presentation materials will be available on the company’s website following the event.
Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event
Nusano’s Dr. Howard Lewin will take part in a virtual event hosted by Truist Securities on Friday, April 21, 2023, at 3:30 p.m. Eastern.
Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah
Nusano’s breakthrough production facility will open Q1 2025 in West Valley City, Utah.
Nusano to Present at Jefferies Inaugural Radiopharma Innovation Summit
Nusano is a featured panelist and speaker at Jefferies Inaugural Radipharma Innovation Summit in New York City on April 3, 2023
Chris Lowe Named CEO
VALENCIA, Calif. and WEST VALLEY CITY, Utah, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced Chris Lowe as the company’s Chief Executive Officer. As Nusano progresses toward...
Health-Tech Company Nusano To Open an Office in Utah
SALT LAKE CITY – July 8, 2021 – The Utah Governor’s Office of Economic Opportunity is pleased to announce that Nusano, Inc. will open an office in Utah, adding up to 92 new high-paying Utah jobs in the next 15 years. “Nusano will be an awesome addition to...
BLOG Posts
U.S. investing in domestic isotope supply
Department of Energy Secretary Jennifer Granholm breaks ground on facility to provide radioisotopes vital to national security, research and health care.
University of Missouri responds to global radioisotope shortage
An unplanned production outage in Europe poses a threat to radioisotope supplies worldwide.
Reuters: EU may face shortage of key materials for diagnostics, cancer treatments
European officials are warning of a potential shortage of medical radioisotopes needed for advanced health care and imaging procedures.
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates